Ovarian Cycle Stages Modulate Alzheimer-Related Cognitive and Brain Network Alterations in Female Mice.
Lauren BroestlKurtresha WordenArturo J MorenoEmily J DavisDan WangBayardo I GarayTanya SinghLaure VerretJorge J PalopDena B DubalPublished in: eNeuro (2018)
Alzheimer's disease (AD) begins several decades before the onset of clinical symptoms, at a time when women may still undergo reproductive cycling. Whether ovarian functions alter substrates of AD pathogenesis is unknown. Here we show that ovarian cycle stages significantly modulate AD-related alterations in neural network patterns, cognitive impairments, and pathogenic protein production in the hAPP-J20 mouse model of AD. Female hAPP mice spent more time in estrogen-dominant cycle stages and these ovarian stages worsened AD-related network dysfunction and cognitive impairments. In contrast, progesterone-dominant stages and gonadectomy attenuated these AD-related deficits. Further studies revealed a direct role for estradiol in stimulating neural network excitability and susceptibility to seizures in hAPP mice and increasing amyloid beta levels. Understanding dynamic effects of the ovarian cycle on the female nervous system in disease, including AD, is of critical importance and may differ from effects on a healthy brain. The pattern of ovarian cycle effects on disease-related networks, cognition, and pathogenic protein expression may be relevant to young women at risk for AD.
Keyphrases
- neural network
- mouse model
- high fat diet induced
- magnetic resonance imaging
- traumatic brain injury
- resting state
- white matter
- computed tomography
- oxidative stress
- adipose tissue
- cognitive decline
- single cell
- functional connectivity
- brain injury
- blood brain barrier
- drug induced
- sleep quality
- binding protein
- pregnancy outcomes